litlas
Log inCreate account

Federico Rojo

Active 2001–2025

120
Papers
19,045
Citations
69
h-index
117
i10-index

Citations

Citations per year for Federico Rojo1976: 1 citations2001: 3 citations2002: 29 citations2003: 136 citations2004: 160 citations2005: 190 citations2006: 157 citations2007: 147 citations2008: 189 citations2009: 211 citations2010: 221 citations2011: 229 citations2012: 183 citations2013: 156 citations2014: 152 citations2015: 159 citations2016: 126 citations2017: 140 citations2018: 151 citations2019: 592 citations2020: 721 citations2021: 812 citations2022: 587 citations2023: 421 citations2024: 730 citations2025: 380 citations2026: 14 citations1977–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,403 citing papers, 24.6% of this breakdownChina: 1,145 citing papers, 11.7% of this breakdownItaly: 593 citing papers, 6.1% of this breakdownSpain: 527 citing papers, 5.4% of this breakdownUnited Kingdom: 496 citing papers, 5.1% of this breakdownGermany: 445 citing papers, 4.6% of this breakdownFrance: 335 citing papers, 3.4% of this breakdownJapan: 310 citing papers, 3.2% of this breakdownCanada: 283 citing papers, 2.9% of this breakdownAustralia: 269 citing papers, 2.7% of this breakdownSwitzerland: 227 citing papers, 2.3% of this breakdownSouth Korea: 203 citing papers, 2.1% of this breakdown
0%24.6%Other 25.9%

Institutions

Fields

  • Medicine55.4%
  • Biochemistry, Genetics and Molecular Biology36.2%
  • Immunology and Microbiology3.7%
  • Computer Science1.9%
  • Neuroscience0.6%
  • Engineering0.5%
  • Other1.7%

Topics

  • HER2/EGFR in Cancer Research6.2%
  • Cancer Cells and Metastasis4.4%
  • Cancer Immunotherapy and Biomarkers4.3%
  • PI3K/AKT/mTOR signaling in cancer3.9%
  • Lung Cancer Treatments and Mutations2.9%
  • Monoclonal and Polyclonal Antibodies Research2.8%
  • Other75.5%

Coauthors

All papers

Open in search
  1. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    Authors: P. Tarantino, Giulia Viale, Michael F. Press, Xin Hu, Frédérique Penault‐Llorca, A. Bardia, Anna Batistatou, H.J. Burstein, L.A. Carey, Javier Cortés, C. Denkert, V. Diéras, William Jacot, A. Koutras, Alizée Lebeau, S. Loibl, Shanu Modi, M.F. Mosele, Elena Provenzano, Giancarlo Pruneri, Jorge S. Reis‐Filho, Federico Rojo, Roberto Salgado, P. Schmid, Stuart J. Schnitt, S.M. Tolaney, Dario Trapani, A. Vincent-Salomon, A.C. Wolff, George Pentheroudakis, Fabrice André, G. Curigliano - Annals of Oncology 2023 cited by 299

  2. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver, Mónica V. Estrada, Paula I. González-Ericsson, Melinda Sanders, Benjamin Solomon, Cinzia Solinas, Gert G. G. M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes A. Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nucíforo, Laura Comerma, E. Aubrey Thompson, Sunil R. Lakhani, Seong-Rim Kim, Stuart J. Schnitt, Cécile Colpaert, Christos Sotiriou, Stefan Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  3. Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer

    Authors: Aurélie Cazet, Mun N. Hui, Benjamin Elsworth, Sunny Z. Wu, Daniel Roden, Chia-Ling Chan, Joanna N. Skhinas, Raphaël Collot, Jessica Yang, Kate Harvey, M. Zahied Johan, Caroline Cooper, Radhika Nair, David Herrmann, Andrea McFarland, Niantao Deng, Manuel Ruíz‐Borrego, Federico Rojo, José Trigo, Susana Bezares, Rosalía Caballero, Elgene Lim, Paul Timpson, Sandra O’Toole, D. Neil Watkins, Thomas R. Cox, Michael S. Samuel, Miguel Martín, Alexander Swarbrick - Nature Communications 2018 cited by 442

  4. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Authors: Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver, Mónica V. Estrada, Paula I. González-Ericsson, Melinda E. Sanders, Benjamin Solomon, Cinzia Solinas, Gert G. G. M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes A. Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nucíforo, Laura Comerma, E. Aubrey Thompson, Sunil R. Lakhani, Seong-Rim Kim, Stuart J. Schnitt, Cécile Colpaert, Christos Sotiriou, Stefan Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 720

  5. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

    Authors: Maria Vittoria Dieci, Nina Radosevic‐Robin, Susan Fineberg, Gert Van den Eynden, Nils Ternès, Frédérique Penault‐Llorca, Giancarlo Pruneri, Timothy M. D’Alfonso, Sandra Demaria, Carlos A. Castañeda, Joselyn Sanchez, Sunil Badve, Stefan Michiels, Veerle Bossuyt, Federico Rojo, Baljit Singh, Torsten O. Nielsen, Giuseppe Viale, Seong-Rim Kim, Stephen M. Hewitt, Stephan Wienert, Sybille Loibl, David L. Rimm, Fraser Symmans, Carsten Denkert, Sylvia Adams, Sherene Loi, Roberto Salgado - Seminars in Cancer Biology 2017 cited by 432

  6. Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer

    Authors: Maurizio Scaltriti, Federico Rojo, Alberto Ocaña, Judit Anido, Marta Guzmán, Javier Cortés, Serena Di Cosimo, Xavier Matías‐Guiu, Santiago Ramón y Cajal, Joaquı́n Arribas, José Baselga - JNCI Journal of the National Cancer Institute 2007 cited by 881

  7. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Authors: Zuzana Kos, Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen, Koen Van de Vijver, Shom Goel, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O. Nielsen, Sunil Badve, W. Fraser Symmans, Christos Sotiriou, David L. Rimm, Stephen M. Hewitt, Carsten Denkert, Sibylle Loibl, Stephen J. Luen, John M. S. Bartlett, Peter Savas, Giancarlo Pruneri, Deborah Dillon, Maggie C.U. Cheang, Andrew Tutt, Jacqueline A. Hall, Marleen Kok, Hugo M. Horlings, Anant Madabhushi, Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, the International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo and 156 more - npj Breast Cancer 2020 cited by 206

  8. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Authors: Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon, Ashish Sharma, Jennifer K. Kerner, Carsten Denkert, Yinyin Yuan, Khalid AbdulJabbar, Stephan Wienert, Peter Savas, Leonie Voorwerk, Andrew H. Beck, Anant Madabhushi, Johan Hartman, Manu Sebastian, Hugo M. Horlings, Jan Hudeček, Francesco Ciompi, David Moore, Rajendra Singh, Elvire Roblin, Marcelo Luiz Balancin, Marie‐Christine Mathieu, Jochen K. Lennerz, Pawan Kirtani, I‐Chun Chen, Jeremy Braybrooke, Giancarlo Pruneri, Sandra Demaria, Sylvia Adams, Stuart J. Schnitt, Sunil R. Lakhani, Federico Rojo, Laura Comerma, Sunil Badve, Mehrnoush Khojasteh, W. Fraser Symmans, Christos Sotiriou, Paula I. González-Ericsson, Katherine L. Pogue–Geile, Rim S. Kim, David L. Rimm, Giuseppe Viale, Stephen M. Hewitt, John M. S. Bartlett, Frédérique Penault–Llorca, Shom Goel, Huang‐Chun Lien, Sibylle Loibl, Zuzana Kos, Sherene Loi, Matthew G. Hanna, Stefan Michiels, Marleen Kok, Torsten O. Nielsen, Alexander J. Lazar, Zsuzsanna Bagó-Horváth, Loes Kooreman, Jeroen van der Laak, Joel Saltz, Brandon D. Gallas, Uday Kurkure, Michael Barnes, Roberto Salgado, Lee Cooper, International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair M. Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo, Anna Sapino, André L. Moreira, Andrea L. Richardson, Andrea Vingiani, Andrew M. Bellizzi, Andrew Tutt, Ángel Guerrero‐Zotano, Anita Grigoriadis, Anna Ehinger, Ana C. Garrido-Castro, Anne Vincent-Salomon, Anne‐Vibeke Lænkholm, Ashley Cimino‐Mathews, Ashok Srinivasan, Balázs Ács, Baljit Singh, Benjamin C. Calhoun, Benjamin Haibe-Kans, Benjamin Solomon, Bibhusal Thapa, Brad H. Nelson, Carlos Castaneda, Carmen Ballesteroes-Merino, Carmen Criscitiello, Carolien Boeckx and 158 more - npj Breast Cancer 2020 cited by 166

  9. A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition

    Authors: C. Theresa Vincent, Etienne P.A. Neve, Jill R. Johnson, Alexander Kukalev, Federico Rojo, Joan Albanell, Kristian Pietras, Ismo Virtanen, Lennart Philipson, Philip L. Leopold, Ronald G. Crystal, Antonio Garcı́a de Herreros, Aristidis Moustakas, Ralf F. Pettersson, Jonas Fuxe - Nature Cell Biology 2009 cited by 636

  10. High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma

    Authors: Marie E. Robert, Josef Rüschoff, Bharat Jasani, Rondell P. Graham, Sunil Badve, Manuel Rodriguez‐Justo, Liudmila L. Kodach, Amitabh Srivastava, Hanlin L. Wang, Laura H. Tang, Giancarlo Troncone, Federico Rojo, Benjamin J. Van Treeck, James Pratt, Iryna Shnitsar, George Kumar, Maria Karasarides, Robert A. Anders - Modern Pathology 2023 cited by 61

  11. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer

    Authors: Arkaitz Carracedo, Li Ma, Julie Teruya‐Feldstein, Federico Rojo, Leonardo Salmena, Andrea Alimonti, Ainara Egia, Atsuo T. Sasaki, George Thomas, Sara C. Kozma, Antonella Papa, Caterina Nardella, Lewis C. Cantley, José Baselga, Pier Paolo Pandolfi - Journal of Clinical Investigation 2008 cited by 1,365

  12. Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

    Authors: Sara S. Oltra, Sara Colomo, Laura Sin, María Pérez-López, Sara Lázaro, Ángela Molina-Crespo, Kyoung-Han Choi, David Ros‐Pardo, Lidia Martínez, Saleta Morales, Cristina González-Paramos, Alba Orantes, Mario Soriano‐Navarro, Alberto Hernández, Aňa Lluch, Federico Rojo, Joan Albanell, Paulino Gómez‐Puertas, Jae‐Kyun Ko, David Sarrió, Gema Moreno‐Bueno - Cell Death and Differentiation 2023 cited by 77

  13. International real-world study of DLL3 expression in patients with small cell lung cancer

    Authors: Federico Rojo, Marcelo Corassa, Dimitriοs Mavroudis, Büğe Öz, Bonne Biesma, Luka Brčić, Patrick Pauwels, Verena Sailer, John R. Gosney, Darko Miljkovic, Carlos Hader, Meijing Wu, Todd Almarez, Frédérique Penault‐Llorca - Lung Cancer 2020 cited by 74

  14. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer

    Authors: Juan Miguel Cejalvo, Eduardo Martínez de Dueñas, Patricia Galván, Susana García‐Recio, Octavio Burgués Gasión, Laia Paré, Silvia Antolín, Rosella Martinello, Isabel Blancas, Bárbara Adamo, Ángel Guerrero‐Zotano, Montserrat Muñoz-Mateu, Paolo Nucíforo, María Vidal, Ramón M. Pérez, José I. Chacón López-Muniz, Rosalía Caballero, Vicente Peg, Eva Carrasco, Federico Rojo, Charles M. Perou, Javier Cortés, Vincenzo Adamo, Joan Albanell, Roger R. Gomis, Aňa Lluch, Aleix Prat - Cancer Research 2017 cited by 251

  15. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

    Authors: Susana García‐Recio, Aatish Thennavan, Michael P. East, Joel S. Parker, Juan Miguel Cejalvo, Joseph P. Garay, Daniel P. Hollern, Xiaping He, Kevin R. Mott, Patricia Galván, Cheng Fan, Sara R. Selitsky, Alisha R. Coffey, David Marron, Fara Brasó‐Maristany, Octavio Burgués, Joan Albanell, Federico Rojo, Aňa Lluch, Eduardo Martínez de Dueñas, Jeffery M. Rosen, Gary L. Johnson, Lisa A. Carey, Aleix Prat, Charles M. Perou - Journal of Clinical Investigation 2020 cited by 110

  16. NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival

    Authors: Aura Muntasell, Federico Rojo, Sònia Servitja, Carlota Rubio-Pérez, Mariona Cabo, David Tamborero, Marcel Costa-García, Maria Martinez‐García, Sílvia Menéndez, Ivonne Vázquez, Aňa Lluch, Abel González-Pérez, Ana Rovira, Miguel López‐Botet, Joan Albanell - Clinical Cancer Research 2019 cited by 131

  17. Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer

    Authors: MohammadA Sabbaghi, Gabriel Gil‐Gómez, Cristina Guardia, Sònia Servitja, Oriol Arpí, Sara García‐Alonso, Sílvia Menéndez, Montserrat Arumí-Uría, Laia Serrano, Marta Salido, Aura Muntasell, Maria Martinez‐García, Sandra Zazo, Cristina Chamizo, Paula Gónzález-Alonso, Juan Madoz‐Gúrpide, Pîlar Eroles, Joaquı́n Arribas, Ignasi Tusquets, Aňa Lluch, Atanasio Pandiella, Federico Rojo, Ana Rovira, Joan Albanell - Clinical Cancer Research 2017 cited by 96

  18. Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation

    Authors: Patricia Fernández‐Nogueira, Mario Mancino, Gemma Fuster, Anna López‐Plana, Patricia Jáuregui, Vanesa Almendro, Estel Enreig, Sílvia Menéndez, Federico Rojo, Aleix Noguera‐Castells, Anke Bill, L. Alex Gaither, Laia Serrano, Leire Recalde‐Percaz, Núria Moragas, Raúl Alonso, Elisabet Ametller, Ana Rovira, Aňa Lluch, Joan Albanell, Pere Gascón, Paloma Bragado - Clinical Cancer Research 2019 cited by 109

  19. PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization

    Authors: Incheol Shin, F. Michael Yakes, Federico Rojo, Nah-Young Shin, Andrei V. Bakin, José Baselga, Carlos L. Arteaga - Nature Medicine 2002 cited by 786

  20. High TGFβ-Smad Activity Confers Poor Prognosis in Glioma Patients and Promotes Cell Proliferation Depending on the Methylation of the PDGF-B Gene

    Authors: Alejandra Bruna, Rachel S. Darken, Federico Rojo, Alberto Ocaña, Silvia Peñuelas, Alexandra Arias, Raquel Parı́s, Avelina Tortosa, Jaume Mora, José Baselga, Joan Seoane - Cancer Cell 2007 cited by 477

  21. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer

    Authors: Gemma Ferrer‐Mayorga, Gonzalo Goméz-López, Antonio Barbáchano, Asunción Fernández‐Barral, Cristina Peña, David G. Pisano, Ramón Cantero, Federico Rojo, Alberto Múñoz, María Jesús Larriba - Gut 2016 cited by 188

  22. Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

    Authors: Anna Adam‐Artigues, Enrique J. Arenas, Alex Martínez-Sabadell, Fara Brasó‐Maristany, Raimundo Cervera, Eduardo Tormo, Cristina Hernándo, María Teresa Martínez, Juan Antonio Carbonell‐Asins, Soraya Simón, Jesús Poveda, Santiago Moragón, Sandra Zazo, Débora Martínez, Ana Rovira, Octavio Burgués, Federico Rojo, Joan Albanell, Begoña Bermejo, Aňa Lluch, Aleix Prat, Joaquı́n Arribas, Pîlar Eroles, Juan Miguel Cejalvo - Science Advances 2022 cited by 56

  23. Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

    Authors: Joan Albanell, José Manuel Pérez-García, Miguel Gil‐Gil, Giuseppe Curigliano, Manuel Ruíz-Borrego, Laura Comerma, Joan Gibert, Meritxell Bellet, Begoña Bermejo, Lourdes Calvo, Juan de la Haba-Rodríguez, Enrique Espinosa, Alessandro Marco Minisini, Vanesa Quiroga, Ana Santaballa, Leonardo Mina, Beatríz Bellosillo, Federico Rojo, Sílvia Menéndez, Miguel Sampayo-Cordero, Crina Popa, Andrea Malfettone, Javier Cortés, Antonio Llombart‐Cussac - Clinical Cancer Research 2022 cited by 37

  24. NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer

    Authors: Sara Santana-Hernández, Jesús Suárez-Olmos, Sònia Servitja, Pau Berenguer-Molins, Marcel Costa-García, Laura Comerma, Anna Rea, Júlia Perera‐Bel, Sílvia Menéndez, Oriol Arpí, Begoña Bermejo, María Teresa Martínez, Juan Miguel Cejalvo, Iñaki Comino‐Méndez, Javier Pascual, Emilio Alba, Miguel López‐Botet, Federico Rojo, Ana Rovira, Joan Albanell, Aura Muntasell - Journal of Experimental & Clinical Cancer Research 2024 cited by 32